FDA Approved: NEBUPENT — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for NEBUPENT (pentamidine isethionate) submitted by Fresenius Kabi USA, LLC. Nebupent is used to prevent Pneumocysti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Jirovecii Pneumonia

Drugs mentioned

• NEBUPENT (Pentamidine isethionate)

Snippet

SUPPL AP for NEBUPENT (PENTAMIDINE ISETHIONATE)